Ranjit Manchanda
0000-0003-3381-5057
Barts Cancer Institute
12 papers found
Refreshing results…
A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot
Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors
Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical Carcinoma
Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
Early removal of Fallopian tubes and delayed removal of ovaries in women at high risk of ovarian cancer
Views of women at high risk of ovarian cancer towards removal of fallopian tubes for ovarian cancer prevention
Systematic genetic testing for personalised ovarian cancer therapy (SIGNPOsT)
Predicting risk of ovarian malignancy improved screening and early detection feasibility study
Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): Common efforts and challenges
Missing publications? Search for publications with a matching author name.